JDSU Renamed Viavi Solutions Following Spinoff of CCOP Business Segment

Viavi Solutions Inc. ("Viavi"), formerly JDSU, announced the completion of the spinoff of its Communications and Commercial Optical Product business segment ("CCOP") on August 1, 2015. With the spinoff complete, JDSU's Network Enablement ("NE"), Service Enablement ("SE") and Optical Security and Performance Products ("OSP") businesses were renamed Viavi.

Viavi will commence "regular-way" trading on the NASDAQ Stock Market on August 4, 2015 under the ticker symbol VIAV. The JDSU ticker symbol will be retired from trading at the close of market today, August 3, 2015.

"This is an important milestone as we mark the successful completion of the spinoff," said Tom Waechter, Viavi's president and chief executive officer. "Viavi is poised to capture the opportunities created by the industry's transition to new network architectures and the need for increased network and application visibility. We believe that the spinoff will improve Viavi's agility and increase focus, allowing us to accelerate our progress and deliver for our customers and shareholders."

About Viavi Solutions
Viavi (NASDAQ: VIAV) software and hardware platforms and instruments deliver end-to-end visibility across physical, virtual and hybrid networks. Precise intelligence and actionable insight from across the network ecosystem optimizes the service experience for increased customer loyalty, greater profitability and quicker transitions to next-generation technologies. Viavi is also a leader in anti-counterfeiting solutions for currency authentication and high-value optical components and instruments for diverse government and commercial applications. Learn more at www.viavisolutions.com and follow us on Viavi Perspectives, LinkedIn, Twitter, YouTube and Facebook

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.